Thrivent Financial for Lutherans
AMED

Thrivent Financial for Lutherans’s Amedisys AMED Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$759K Buy
7,711
+32
+0.4% +$3.15K ﹤0.01% 1949
2025
Q1
$711K Sell
7,679
-27
-0.4% -$2.5K ﹤0.01% 1917
2024
Q4
$700K Buy
7,706
+39
+0.5% +$3.54K ﹤0.01% 2098
2024
Q3
$740K Sell
7,667
-218
-3% -$21K ﹤0.01% 2073
2024
Q2
$724K Sell
7,885
-293
-4% -$26.9K ﹤0.01% 2043
2024
Q1
$754K Buy
8,178
+26
+0.3% +$2.4K ﹤0.01% 2047
2023
Q4
$775K Sell
8,152
-19
-0.2% -$1.81K ﹤0.01% 2000
2023
Q3
$763K Sell
8,171
-240
-3% -$22.4K ﹤0.01% 1898
2023
Q2
$769K Sell
8,411
-48,658
-85% -$4.45M ﹤0.01% 1964
2023
Q1
$4.2M Buy
57,069
+36,623
+179% +$2.69M 0.01% 881
2022
Q4
$1.71M Sell
20,446
-30,054
-60% -$2.51M ﹤0.01% 1356
2022
Q3
$4.89M Buy
50,500
+29,378
+139% +$2.84M 0.01% 809
2022
Q2
$2.22M Buy
21,122
+27
+0.1% +$2.84K 0.01% 1176
2022
Q1
$3.63M Sell
21,095
-77
-0.4% -$13.3K 0.01% 1007
2021
Q4
$3.43M Sell
21,172
-217,358
-91% -$35.2M 0.01% 1064
2021
Q3
$35.6M Sell
238,530
-324,330
-58% -$48.4M 0.07% 299
2021
Q2
$138M Buy
562,860
+199,839
+55% +$48.9M 0.28% 79
2021
Q1
$96.1M Buy
363,021
+354,431
+4,126% +$93.9M 0.21% 113
2020
Q4
$2.52M Sell
8,590
-154
-2% -$45.2K 0.01% 1170
2020
Q3
$2.07M Sell
8,744
-200
-2% -$47.3K 0.01% 1140
2020
Q2
$1.78M Buy
8,944
+516
+6% +$102K 0.01% 1133
2020
Q1
$1.55M Hold
8,428
0.01% 1070
2019
Q4
$1.41M Buy
8,428
+74
+0.9% +$12.4K ﹤0.01% 1239
2019
Q3
$1.09M Buy
8,354
+653
+8% +$85.5K ﹤0.01% 1350
2019
Q2
$935K Buy
7,701
+184
+2% +$22.3K ﹤0.01% 1458
2019
Q1
$927K Sell
7,517
-12,912
-63% -$1.59M ﹤0.01% 1428
2018
Q4
$2.39M Buy
20,429
+675
+3% +$79K 0.01% 778
2018
Q3
$2.47M Buy
19,754
+125
+0.6% +$15.6K 0.01% 826
2018
Q2
$1.68M Buy
19,629
+419
+2% +$35.8K 0.01% 980
2018
Q1
$1.16M Buy
19,210
+1,539
+9% +$92.9K ﹤0.01% 1148
2017
Q4
$931K Buy
17,671
+348
+2% +$18.3K ﹤0.01% 1305
2017
Q3
$969K Buy
17,323
+410
+2% +$22.9K ﹤0.01% 1179
2017
Q2
$1.06M Buy
16,913
+1,210
+8% +$76K ﹤0.01% 1091
2017
Q1
$802K Buy
15,703
+570
+4% +$29.1K ﹤0.01% 1291
2016
Q4
$645K Buy
15,133
+880
+6% +$37.5K ﹤0.01% 1381
2016
Q3
$676K Buy
14,253
+540
+4% +$25.6K ﹤0.01% 1312
2016
Q2
$692K Buy
13,713
+460
+3% +$23.2K ﹤0.01% 1264
2016
Q1
$641K Buy
13,253
+1,120
+9% +$54.2K ﹤0.01% 1269
2015
Q4
$477K Buy
12,133
+350
+3% +$13.8K ﹤0.01% 1373
2015
Q3
$447K Sell
11,783
-1,350
-10% -$51.2K ﹤0.01% 1262
2015
Q2
$522K Buy
13,133
+600
+5% +$23.8K ﹤0.01% 1091
2015
Q1
$336K Buy
12,533
+700
+6% +$18.8K ﹤0.01% 1318
2014
Q4
$347K Sell
11,833
-250
-2% -$7.33K ﹤0.01% 1306
2014
Q3
$244K Sell
12,083
-50
-0.4% -$1.01K ﹤0.01% 1484
2014
Q2
$203K Buy
12,133
+300
+3% +$5.02K ﹤0.01% 1625
2014
Q1
$176K Hold
11,833
﹤0.01% 1495
2013
Q4
$173K Buy
11,833
+200
+2% +$2.92K ﹤0.01% 1516
2013
Q3
$200K Buy
11,633
+200
+2% +$3.44K ﹤0.01% 1437
2013
Q2
$133 Buy
+11,433
New +$133 ﹤0.01% 1511